Zhonghua Zhong Liu Za Zhi. 2017 Jul 23;39(7):502-508. doi: 10.3760/cma.j.issn.0253-3766.2017.07.005.
[Effect of 21-gene recurrence score on chemotherapy decisions for patients with estrogen receptor-positive, epidermal growth factor receptor 2-negative and lymph node-negative early stage-breast cancer].
[Article in Chinese; Abstract available in Chinese from the publisher]
Mao Y1, Chen XS1, Liang Y1, Wu JY1, Huang O1, Zong Y1, Fang Q1, He JR1, Zhu L1, Chen WG1, Li YF1, Lin L2, Fei XC3, Shen KW1.
21-gene recurrence score; Antineoplastic combined chemotherapy protocols; Breast neoplasms; Lymph nodes; Receptor, epidermal growth factor; Receptors, estrogen